MAR 06, 2019 04:16 PM PST

Benefits of a Strong Body

As far back as Ancient Greece, a sculptured physique has been heralded as the pinnacle of physical perfection. But now, researchers from Japan have found that increased muscle mass doesn't just make you look good; it could save your life.

In a study published in Scientific Reports, researchers from Osaka University have revealed that sarcopenia, or the loss of skeletal muscle mass, is significantly associated with an inadequate response to treatments for advanced non-small cell lung cancer (NSCLC).

These treatments, known as programmed death (PD)-1 inhibitors, are an exciting new class of drugs used to fight many different types of cancer, including NSCLC. They work with the patient's immune system, increasing its ability to attack cancer cells. Unsurprisingly, the efficacy of PD-1 inhibitors relies heavily on the function of the host's immune system. At present, only a subset of patients achieves good long-term progression-free survival rates, something the researchers at Osaka University aimed to address.

"Sarcopenia is a well-known risk factor associated with poor outcomes for several cancer types," says the lead author of the study, Takayuki Shiroyama. "Because muscle degradation is associated with a dysregulated immune response, we wanted to investigate how, in lung cancer patients, sarcopenia impacts the efficacy of PD-1 inhibitor therapy."

To do this, the researchers examined the medical records and treatment outcomes of 42 patients with advanced NSCLC who were treated with PD-1 inhibitors. Only patients who had undergone an assessment of skeletal muscle mass before treatment were included in the analysis.

"The results were surprisingly emphatic," explains Atsushi Kumanogoh, senior author of the study. "We found that the treatment outcomes for patients with sarcopenia at the start of therapy were far worse than those without."

While 38.1% of non-sarcopenia patients remained in remission one year after treatment, only 10.1% of sarcopenia patients showed no sign of tumor progression at the same time point. "Our findings suggest that baseline skeletal muscle mass has a substantial impact on PD-1 inhibitor efficacy. As such, skeletal muscle mass might be useful for predicting whether treatment is likely to be effective," says Shiroyama.

Given that muscle wasting is a common occurrence in patients with advanced cancer, several new drugs that can increase skeletal muscle mass in cancer patients could be vitally important for future treatment strategies. By increasing muscle mass before treatment, a higher number of patients are likely to achieve optimal long-term treatment outcomes from PD-1-inhibitor therapy.

Sources: Science Daily, Scientific Reports, YouTube

About the Author
You May Also Like
NOV 21, 2018
Immunology
NOV 21, 2018
HIV Persisting How?
A team of researchers have identified an HIV reservoir...
NOV 25, 2018
Health & Medicine
NOV 25, 2018
Why Does E. Coli Make us Sick?
  Escherichia coli, or E. coli refer to a diverse group of of bacteria commonly found in the lower intestine of warm blooded animals. While E. coli ga...
DEC 11, 2018
Immunology
DEC 11, 2018
Autoimmunity Caused By Genetic Mutation
Research reveals a genetic mutation causes a protein binding site to alter its structure resulting in the development of chronic inflammation and autoimmunity...
JAN 20, 2019
Drug Discovery
JAN 20, 2019
Combination Therapeutic Effective for Leishmaniasis and HIV Patients
In a study published in PLOS Neglected Diseases, a special combination therapy has been proven for efficacy in cases of coinfection with Visceral leishmani...
MAR 25, 2019
Drug Discovery
MAR 25, 2019
Aspirin Combats Tuberculosis
Tuberculosis is a global infection far from being eradicated. It currently infects more than 1,400 people per year in Australia. The deadliest form and exp...
APR 09, 2019
Health & Medicine
APR 09, 2019
Toxic Air is Shortening Children's Lifespans
According to the State of Global Air 2019 report, air pollution is currently shortening life expectancy by an average of 20 months worldwide. This means th...
Loading Comments...